Residency · Residency · Preventive Medicine

Maternal Mortality in the United States: A Preventable Crisis

Introduction

The United States has the highest maternal mortality ratio (MMR) among high-income countries, at approximately 32.9 deaths per 100,000 live births (2021), compared to rates of 2-10 in peer nations. Maternal mortality has been rising in the U.S. over the past several decades while declining in virtually every other developed country. An estimated 80% of pregnancy-related deaths in the U.S. are preventable, according to state Maternal Mortality Review Committees. Profound racial disparities exist: Black women die at 3-4 times the rate of White women, and Indigenous women at approximately 2.5 times the rate.

Definitions and Measurement

Key Definitions

Maternal death (WHO): Death of a woman while pregnant or within 42 days of termination of pregnancy from any cause related to or aggravated by pregnancy or its management. Late maternal death: Death from obstetric causes occurring between 42 days and 1 year postpartum. Pregnancy-related death (CDC): Death during pregnancy or within 1 year of the end of pregnancy from any cause related to or aggravated by the pregnancy. Pregnancy-associated death: Death during pregnancy or within 1 year from any cause, regardless of relationship to pregnancy. Severe maternal morbidity (SMM): Unexpected outcomes of labor and delivery resulting in significant consequences (ICU admission, blood transfusion, hysterectomy, eclampsia); affects approximately 50,000-60,000 women annually, an incidence approximately 100 times greater than maternal mortality.

Measurement Challenges

The U.S. added a pregnancy checkbox to death certificates in 2003 (adopted by all states by 2017), improving identification but also leading to artifactual increases due to false positives. Underreporting of maternal deaths is well-documented; many pregnancy-related deaths are missed when they occur remote from delivery or from indirect causes. Maternal Mortality Review Committees (MMRCs) in 40+ states conduct in-depth reviews of pregnancy-related deaths using standardized CDC methodology to determine preventability, contributing factors, and recommendations.

<image>Line graph showing maternal mortality ratios in the United States from 1990 to 2023 compared to peer high-income countries (UK, Canada, Germany, Japan, Australia), demonstrating the divergent trend where the U.S. rate has increased while other countries have declined, with racial disparities shown as separate lines for Black, American Indian/Alaska Native, Hispanic, and White women in the U.S.</image>

Leading Causes of Maternal Death

Timing of Death

During pregnancy: Approximately 31% of pregnancy-related deaths. Day of delivery: Approximately 17%. 1-42 days postpartum: Approximately 19%. 43 days to 1 year postpartum: Approximately 33%; this late postpartum period accounts for the largest proportion and is often underrecognized.

Causes

Mental health conditions (including substance use and suicide): Leading cause of pregnancy-related death, accounting for approximately 23% of deaths; predominantly occurs in the late postpartum period. Cardiovascular conditions (cardiomyopathy, other cardiac conditions): Approximately 14%; peripartum cardiomyopathy may present weeks to months postpartum. Hemorrhage: Approximately 14%; most hemorrhage deaths occur on the day of delivery and are highly preventable through early recognition and standardized response. Infection/sepsis: Approximately 9%; includes chorioamnionitis, endometritis, wound infections, and non-obstetric infections. Hypertensive disorders of pregnancy (preeclampsia, eclampsia, HELLP syndrome): Approximately 7%; preeclampsia can present up to 6 weeks postpartum. Thrombotic embolism: Approximately 9%; pregnancy is a hypercoagulable state with elevated VTE risk through 6 weeks postpartum. Amniotic fluid embolism: Rare but highly fatal.

Racial and Ethnic Disparities

Magnitude and Patterns

Black women: 3-4 times more likely to die from pregnancy-related causes; disparity persists across all educational levels and income strata. American Indian/Alaska Native women: Approximately 2-2.5 times the rate of White women; likely underestimated due to racial misclassification. Hispanic women: Rates are lower than White women overall (the "Latina paradox") but with significant variation by country of origin and nativity. Disparities are wider for specific causes: Black women have particularly elevated risk for cardiomyopathy, preeclampsia/eclampsia, and hemorrhage.

Contributing Factors

Structural racism: Residential segregation, environmental exposures, economic marginalization, and differential access to quality care. Chronic stress and weathering: The cumulative physiological impact of racism accelerates biological aging and increases susceptibility to pregnancy complications. Quality of care differences: Black women are more likely to deliver in hospitals with higher maternal complication rates; lower rates of timely treatment for hemorrhage and hypertension. Implicit bias: Provider assumptions about Black patients' pain tolerance, compliance, and symptom validity contribute to delayed diagnosis and treatment. Insurance disparities: Black women are more likely to be uninsured or have Medicaid; postpartum Medicaid coverage traditionally ended at 60 days (now extended to 12 months in many states)

<image>Infographic showing the racial disparity in maternal mortality with two key visuals: a bar chart comparing pregnancy-related mortality ratios by race/ethnicity (Black, AI/AN, White, Hispanic, Asian/Pacific Islander), and a pie chart showing the leading causes of death with proportional breakdowns by race, highlighting that disparities persist even after adjusting for education, income, and comorbidities</image>

Prevention Strategies

Clinical Interventions

AIM (Alliance for Innovation on Maternal Health) bundles: Standardized evidence-based protocols for the leading causes of maternal death. Obstetric hemorrhage: Quantitative blood loss measurement, hemorrhage risk assessment, massive transfusion protocols, simulation training. Severe hypertension: Treatment within 60 minutes of recognition (IV labetalol or hydralazine, oral nifedipine, IV magnesium sulfate); has been shown to prevent strokes and death. Sepsis: Early recognition, maternal sepsis screening tools, and timely antibiotic administration. Venous thromboembolism: Risk assessment and appropriate thromboprophylaxis during pregnancy and postpartum. Perinatal Quality Collaboratives (PQCs): State-based QI networks that implement AIM bundles and track outcomes; California's CMQCC reduced maternal mortality by 55% between 2006 and 2013.

Health System and Policy Interventions

Postpartum Medicaid extension: Extending coverage from 60 days to 12 months postpartum; as of 2024, 46 states have implemented this. Levels of maternal care: Ensuring that high-risk pregnancies are managed in facilities with appropriate capabilities (ACOG/SMFM levels of maternal care designation) Maternal Mortality Review Committees: Systematic, multidisciplinary review of every maternal death to identify systemic failures and recommendations. Doula support: Continuous labor support by doulas is associated with reduced cesarean delivery rates, reduced preterm birth among Black women, and improved patient experience; Medicaid coverage for doula services is expanding. Group prenatal care (CenteringPregnancy): Associated with reduced preterm birth, improved prenatal knowledge, and greater satisfaction, particularly for Black women.

Addressing Root Causes

Anti-racism training: Moving beyond implicit bias training to structural changes in healthcare delivery. Diversifying the perinatal workforce: Increasing representation of Black, Indigenous, and Latina midwives, nurses, obstetricians, and doulas. Community-based programs: Community health workers, home visiting programs, and peer support for high-risk populations. Listening to patients: The experience of being dismissed or not believed is a recurring theme in maternal death reviews, particularly for Black women; systems must be redesigned to center patient voices.

The Fourth Trimester

The postpartum period (particularly the first 12 weeks) requires comprehensive care addressing physical recovery, mental health, infant care, and social support. Traditional U.S. model of a single 6-week postpartum visit is inadequate; ACOG recommends contact within 3 weeks and a comprehensive visit within 12 weeks. Postpartum depression and anxiety screening should occur at multiple points; Edinburgh Postnatal Depression Scale (EPDS) is the most validated tool. Contraceptive counseling and access, particularly long-acting reversible contraception (LARC) immediately postpartum, supports birth spacing and reproductive autonomy. Breastfeeding support, including lactation consultation and workplace protections, improves maternal and infant outcomes.

<image>Timeline of the pregnancy and postpartum continuum showing intervention opportunities at each phase: preconception (chronic disease management, folic acid, substance use screening), prenatal (risk assessment, group care, social determinants screening), intrapartum (AIM bundles, safety protocols, respectful care), early postpartum (mental health screening, VTE prophylaxis, hemorrhage monitoring), and late postpartum up to one year (Medicaid extension, chronic disease follow-up, mental health/substance use treatment, contraception), with leading causes of death mapped to the time period where they are most likely to occur</image>

Key Clinical Pearls

Eighty percent of pregnancy-related deaths are preventable; the leading preventable factors are patient/family contributing factors (delayed seeking care, lack of knowledge) and provider contributing factors (missed/delayed diagnosis, ineffective treatment) Mental health conditions (including suicide and overdose) are now the leading cause of pregnancy-related death; screening and treatment must extend through the full year postpartum. The Black-White maternal mortality disparity persists even when controlling for education and income, demonstrating that individual-level socioeconomic factors alone cannot explain the gap; structural racism and healthcare quality differences are primary drivers. Standardized safety bundles (AIM/CMQCC) for hemorrhage and hypertension have demonstrated dramatic reductions in maternal mortality and should be implemented in every delivery facility.

References

1. Petersen EE, Davis NL, Goodman D, et al. Vital Signs: Pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 states, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;68(18):423-429.
2. Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol. 2017;130(2):366-373.
3. Main EK, Cape V, Abreo A, et al. Reduction of severe maternal morbidity from hemorrhage using a state perinatal quality collaborative. Am J Obstet Gynecol. 2017;216(3):298.e1-298.e11.
4. Howell EA. Reducing disparities in severe maternal morbidity and mortality. Clin Obstet Gynecol. 2018;61(2):387-399.

Read this lecture as Markdown